Andrew J Ashworth. Show Affiliations »
Abstract
Entities: Gene
Mesh： See more » Age FactorsAgedAged, 80 and overCardiovascular Diseases/chemically inducedCardiovascular Diseases/epidemiologyCyclooxygenase 2 Inhibitors/administration & dosageCyclooxygenase 2 Inhibitors/adverse effectsDose-Response Relationship, DrugDrug Administration ScheduleFemaleFollow-Up StudiesHumansLactones/adverse effectsLactones/therapeutic useMaleOsteoarthritis/drug therapyRisk FactorsSulfones/adverse effectsSulfones/therapeutic useTime Factors
Substances： See more » Cyclooxygenase 2 InhibitorsLactonesSulfonesrofecoxib
Year: 2007 PMID： 17296963 PMCID： PMC1800581 DOI： 10.1503/cmaj.1060144
Source DB: PubMed Journal: CMAJ ISSN： 0820-3946 Impact factor: 8.262